Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man

Adriaan G. Holleboom, Helen Karlsson, Ruei Shiuan Lin, Thomas M. Beres, Jeroen A. Sierts, Daniel S. Herman, Erik S.G. Stroes, Johannes M. Aerts, John J.P. Kastelein, Mohammad M. Motazacker, Geesje M. Dallinga-Thie, Johannes H.M. Levels, Aeilko H. Zwinderman, Jonathan G. Seidman, Christine E. Seidman, Stefan Ljunggren, Dirk J. Lefeber, Eva Morava, Ron A. Wevers, Timothy A. FritzLawrence A. Tabak, Mats Lindahl, G. Kees Hovingh, Jan Albert Kuivenhoven

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man'. Together they form a unique fingerprint.

Medicine & Life Sciences